ABSTRACT
This chapter accomplishes three tasks: first to posit that humans in the form of clinical research patient (CRP) can be subject to bio-objectification process through their involvement in medical R&D. second to display that bio-objectification processes can allow for differential configurations of the CRP across the multidisciplinary research team; and the third to show the resistance of the CRP to move from this level of bio-objectification to one that would see the realignment of these different configurations for the stabilization of prospective techno-sciences like pharmacogenetics (PGx). The increasing linkages between patients, medical knowledge production processes, and their associated clinical technologies reflects bio-objectification processes that are breaking-down boundaries between patients and technologies, patient's status as research subject and research object, and between conventional divisions between health care and medical R&D. By examining how PGx R&D differently bio-objectifies CRP, and attempts to use them as bio-objects, people are in a position to observe how epistemology configures materiality, and how materiality configures epistemologies.
